Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
248.50    0.00 (0.00%)
Bid:
240.00
Ask:
0.00
Spread: 11.00 (4.583%)
Market Cap: £144.97m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

Trading Update

9 Jan 2014 07:00

RNS Number : 2582X
Gleeson(M J)Group PLC
09 January 2014
 



MJ GLEESON GROUP PLC

('Gleeson' or 'the Group')

TRADING UPDATE

 

MJ Gleeson Group plc (GLE.L), the urban regeneration and strategic land specialist, today issues the following trading update ahead of its interim results for the six months ended 31 December 2013, which are expected to be announced on Monday 17 February 2014.

 

The Group continues to trade well and expects profits for H1 2014 to show a strong increase over H1 2013. Beyond that, the Board is confident of delivering a result for the full year which is in line with current expectations.

 

Gleeson Homes

 

Gleeson Homes sold 258 homes during the period, an increase of 56% on the previous year's total of 165, and has a current forward order book of 240 homes.

 

The Government's Help to Buy initiative has continued to be attractive to our customers, with 44% of completions in the period benefitting from the scheme.

 

The business currently has 33 active sites, compared with 27 in the corresponding period. Gleeson Homes is in active discussions regarding the acquisition of further sites which, if purchased, will add 1,940 plots to the land pipeline, taking the total number of plots to in excess of 6,000.

 

Gleeson Strategic Land

 

Gleeson Strategic Land sold two sites in the period, with a combined acreage of four acres and planning permission for 42 plots. In addition, the division achieved planning permission on three sites which will deliver a combined total of 380 plots when the sites are sold in due course. Twelve planning applications with the potential to deliver a total of 1,737 plots were submitted during the period.

 

Also during the period, a further four land interests of 81 acres, with the potential to deliver 545 plots, were secured. The Gleeson Strategic Land portfolio now comprises 70 land interests of 3,781 gross acres, which have the potential to deliver 21,600 plots.

 

Jolyon Harrison, Chief Executive, commented:

 

"The first half performance of both Gleeson Homes and Gleeson Strategic Land has been encouraging, with first half profits expected to be strongly ahead of last year. The Group continues to benefit from our twin track strategy focussed on providing low cost family homes in the North of England, and strategic land promotion in the South."

 

9 January 2014

 

Enquiries:

 

MJ Gleeson Group plc

Tel: +44 1252 360 300

Jolyon Harrison

Chief Executive Officer

Alan Martin

Chief Financial Officer

College Hill

Tel: +44 20 7457 2020

Helen Tarbet

Mark Garraway

N+1 Singer

Shaun Dobson

Tel: +44 20 7496 3000

Gillian Martin

 

 

 

Notes to Editors

 

MJ Gleeson Group plc operates in the house building sector through the following business units; Gleeson Homes, which focuses on estate regeneration and housing development on brownfield land in the North of England; and Gleeson Strategic Land, which purchases options over land in the South of England with the objective of enhancing the value of the site concerned by securing residential planning permission.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSSFSMUFLSELF
Date   Source Headline
25th Mar 20204:35 pmRNSPrice Monitoring Extension
25th Mar 20203:38 pmRNSCovid-19 Update
23rd Mar 20204:40 pmRNSSecond Price Monitoring Extn
23rd Mar 20204:36 pmRNSPrice Monitoring Extension
13th Mar 202012:08 pmRNSSecond Price Monitoring Extn
13th Mar 202012:02 pmRNSPrice Monitoring Extension
9th Mar 20209:49 amRNSDirector/PDMR Shareholding
28th Feb 20207:00 amRNSTotal Voting Rights
13th Feb 202012:02 pmRNSPrice Monitoring Extension
13th Feb 20207:00 amRNSHalf-year Report
10th Feb 20202:32 pmRNSDirector/PDMR Shareholding
31st Jan 20207:00 amRNSTotal Voting Rights
9th Jan 20207:00 amRNSNotice of Results and Trading Update
8th Jan 20206:05 pmRNSDirector/PDMR Shareholding
31st Dec 20197:00 amRNSTotal Voting Rights
20th Dec 20196:09 pmRNSExercise of options, PDMR Dealing and TVR
19th Dec 201912:07 pmRNSSecond Price Monitoring Extn
19th Dec 201912:02 pmRNSPrice Monitoring Extension
18th Dec 201910:15 amRNSDirector/PDMR Shareholding
11th Dec 20195:22 pmRNSPerformance Share Plan award to Directors/PDMRs
9th Dec 201911:31 amRNSDirector/PDMR Shareholding
5th Dec 20193:18 pmRNSResult of AGM
5th Dec 20197:00 amRNSAGM Statement
3rd Dec 20194:07 pmRNSTotal Voting Rights
2nd Dec 20197:01 amRNSIncentive Plan Share Issue
2nd Dec 20197:00 amRNSAppointment of Chief Executive Officer
29th Nov 20197:00 amRNSTotal Voting Rights
12th Nov 20193:40 pmRNSPerformance Share Plan award to Directors/PDMRs
11th Nov 201910:12 amRNSDirector/PDMR Shareholding
4th Nov 20197:00 amRNSNotice of AGM
31st Oct 201912:13 pmRNSRe Committee Appointments
31st Oct 20197:00 amRNSTotal Voting Rights
16th Oct 20193:58 pmRNSHolding(s) in Company
9th Oct 201912:05 pmRNSDirector/PDMR Shareholding
9th Oct 201911:46 amRNSDirector/PDMR Shareholding
8th Oct 20192:09 pmRNSExercise of Options and Total Voting Rights
30th Sep 20197:00 amRNSTotal Voting Rights
24th Sep 20197:00 amRNSAppointment of Non-Executive Directors
24th Sep 20197:00 amRNSDirector/PDMR Shareholding
16th Sep 20197:00 amRNSFinal Results
10th Sep 20195:35 pmRNSDirector/PDMR Shareholding
30th Aug 20197:00 amRNSTotal Voting Rights
14th Aug 20194:35 pmRNSPrice Monitoring Extension
8th Aug 20199:32 amRNSDirector/PDMR Shareholding
7th Aug 20191:40 pmRNSHolding(s) in Company
31st Jul 20197:00 amRNSTotal Voting Rights
11th Jul 201910:55 amRNSDirector/PDMR Shareholding
4th Jul 20197:00 amRNSTrading Update
28th Jun 20197:00 amRNSTotal Voting Rights
10th Jun 20192:16 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.